Oct 23, 2025 18:25
PTGX - Protagonist Therapeutics, Inc
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 84.24 1.8 (2.14%) | 0.01 (0.01%) | -0.05 (-0.06%) | -0.01 (-0.01%) | --- | 1.8 (2.14%) | --- | --- |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.55
- Diluted EPS:
- -0.55
- Basic P/E:
- -156.4364
- Diluted P/E:
- -156.4364
- RSI(14) 1m:
- 44.59
- VWAP:
- 86.05
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Oct 21, 2025 21:03
Oct 15, 2025 09:20
Oct 14, 2025 12:51
Oct 13, 2025 14:30
Oct 12, 2025 19:14
Oct 10, 2025 23:07
Oct 10, 2025 17:06
Sep 17, 2025 19:15
Aug 07, 2025 04:34